Clinical trial
A Study of the Effect of Cardiac Resynchronisation Therapy (CRT) on Chemosensitivity in Patients With Chronic Heart Failure With and Without Sleep Disordered Breathing.
NCT01213537 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study of the Effect of Cardiac Resynchronisation Therapy (CRT) on Chemosensitivity in Patients With Chronic Heart Failure With and Without Sleep Disordered Breathing.
- Lead sponsor
- Imperial College London
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 31, 2010
- Completion date
- October 31, 2011
- Enrollment
- 182 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.